Data reinforce dose-dependent mechanism with IMNN-001 100mg/m 2 dose associated with 20% increase in IL-12 levels compared to 79mg/m 2 dose. Results from OVATION 2 Study continue ...

The trial was able to elicit more than double the microdystrophin gene in patients after 90 days of treatment.

Taysha Gene Therapies, Inc. (Nasdaq: TSHA), a clinical-stage biotechnology company focused on advancing adeno-associated ...

The biotech industry is ripe with great investment opportunities due to technological advancements such as artificial ...

The introduction of anti-VEGF agents has revolutionized the field of medical retina care by reducing rates of vision loss and ...

The PORTOS assay could indicate when or when not to offer dose-escalated radiation for localized prostate cancer.

South African medical doctors have been working on a study to find the cure for HIV. According to SABC News, South African ...

BOISE — Senate committee members heard arguments on a bill that would place a 10-year pause on administering mRNA vaccines in ...

Bayer's subsidiary AskBio received approval from the U.S. drug regulator to accelerate the development of its investigational gene therapy to treat moderate-stage Parkinson's disease.

Senate committee members heard arguments on a bill that would place a 10-year pause on administering mRNA vaccines in Idaho on Monday but did not take a vote.

We assign Siegfried a Medium Morningstar Uncertainty Rating. Its business is relatively stable, with high switching costs and good visibility due to long-term customer contracts. However, small ...

MUSC health has established the Rena N. Grant Sickle Cell Center to help treat those suffering from sickle cell disease. This ...